The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Phase I study of pasotuxizumab (AMG 212/BAY 2010112), a PSMA-targeting BiTE (Bispecific T-cell Engager) immune therapy for metastatic castration-resistant prostate cancer (mCRPC).
 
Horst-Dieter Hummel
Travel, Accommodations, Expenses - Boehringer Ingelheim; Johnson & Johnson
 
Peter Kufer
Employment - Amgen
Leadership - Amgen
Stock and Other Ownership Interests - Amgen
Patents, Royalties, Other Intellectual Property - Amgen
 
Carsten Grüllich
Honoraria - Amgen; Bristol-Myers Squibb; Eisai; Ipsen; Janssen Oncology; MSD Oncology; Pfizer; Roche/Genentech; Sanofi/Aventis
Consulting or Advisory Role - Bristol-Myers Squibb; Eisai; Ipsen; Novartis; Pfizer; Roche/Genentech; Sanofi
Research Funding - Eisai; Ipsen
Travel, Accommodations, Expenses - Gilead Sciences; Ipsen; Novartis; Roche/Genentech
 
Barbara Deschler-Baier
No Relationships to Disclose
 
Manik Chatterjee
No Relationships to Disclose
 
Maria-Elisabeth Goebeler
Consulting or Advisory Role - Bristol-Myers Squibb; Gilead Sciences; Janssen-Cilag; Novartis; Pfizer; Roche
Expert Testimony - Bristol-Myers Squibb; Expert Meetings; Novartis
Travel, Accommodations, Expenses - Bristol-Myers Squibb; Gilead Sciences; Janssen-Cilag; Novartis; Pfizer; Roche
 
Kurt Miller
Honoraria - Astellas Pharma; Bayer Schering Pharma; Bristol-Myers Squibb; Ferring; Janssen Oncology; Merck Sharp & Dohme; Novartis; Pfizer; Roche
Consulting or Advisory Role - Bayer Schering Pharma; Bristol-Myers Squibb; Ferring; Janssen Oncology; Merck Sharp & Dohme; Novartis; Pfizer; Roche
Speakers' Bureau - Janssen Oncology
Travel, Accommodations, Expenses - Bayer Schering Pharma; Bristol-Myers Squibb; Ferring; Janssen Oncology; Merck Sharp & Dohme; Novartis; Roche/Genentech
 
Maria De Santis
Honoraria - Astellas Pharma; Bayer; Novartis; Pierre Fabre; Roche/Genentech
Consulting or Advisory Role - Amgen; Astellas Pharma; AstraZeneca; Basilea; Bayer; BioClin Therapeutics; BioSyn Healthy Pharma; Bristol-Myers Squibb; Ferring; GlaxoSmithKline; Ipsen; Janssen; Merck Sharp & Dohme; Pierre Fabre; Roche/Genentech; Sandoz-Novartis; Sanofi; Seagen; Synthon; Takeda
Research Funding - Pierre Fabre
Travel, Accommodations, Expenses - Astellas Pharma; Bayer; Bristol-Myers Squibb; Ipsen; Janssen; Roche; Sanofi
 
Wolfgang C. Loidl
Consulting or Advisory Role - Bristol-Myers Squibb; Merck Sharp & Dohme; Novartis; Roche Pharma AG
Travel, Accommodations, Expenses - Bristol-Myers Squibb; Ipsen; Janssen Oncology; Roche Pharma AG
 
Andreas Buck
Stock and Other Ownership Interests - Bayer
Consulting or Advisory Role - Eisai
Patents, Royalties, Other Intellectual Property - Scintomics
 
Sabine Wittemer-Rump
Employment - Bayer
Stock and Other Ownership Interests - Bayer
 
Goekben Koca
Employment - Bayer
 
Oliver Boix
Employment - Bayer
Leadership - Bayer
Stock and Other Ownership Interests - Bayer
 
Wolf-Dietrich Doecke
Employment - Bayer
Stock and Other Ownership Interests - Bayer
 
Sabine Stienen
Employment - Amgen
Stock and Other Ownership Interests - Amgen
Patents, Royalties, Other Intellectual Property - Amgen
 
Cyrus Sayehli
Honoraria - Bristol-Myers Squibb
Travel, Accommodations, Expenses - Bristol-Myers Squibb; Celgene
 
Ralf C. Bargou
Honoraria - Amgen; Cellex; GEMoaB; Molecular Partners; Novartis
Consulting or Advisory Role - Amgen; Cellex; GEMoaB; Molecular Partners; Novartis
Patents, Royalties, Other Intellectual Property - Amgen; Blinatumomab
Travel, Accommodations, Expenses - Amgen; Cellex; GEMoaB; Molecular Partners; Novartis